SQSTM1 mutations - Bridging Paget disease of bone and ALS/FTLD

Experimental Cell Research

Volumn 325, Issue 1, 2014, Pages 27-37

  Rea, Sarah L ^a,b   Majcher, Veronika ^b   Searle, Mark S ^b   Layfield, Rob ^b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Autophagy; Frontotemporal lobar degeneration; P62; Paget disease; SQSTM1

Indexed keywords

CELL PROTEIN; I KAPPA B; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LITHIUM; NERVE GROWTH FACTOR; OPTINEURIN; OSTEOCLAST DIFFERENTIATION FACTOR; POLYUBIQUITIN; PROTEIN KINASE C GAMMA; PROTEIN P62; TAR DNA BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUILIN 2; UBIQUITIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGOSOME; AUTOPHAGY; CELL INCLUSION; COMPLEX FORMATION; DISEASE ASSOCIATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; FRONTOTEMPORAL DEMENTIA; GENE; GENE MUTATION; HUMAN; MOTONEURON; NEUROPROTECTION; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PAGET BONE DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SQSTM1 GENE;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; FRONTOTEMPORAL LOBAR DEGENERATION; P62; PAGET DISEASE; SQSTM1;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AUTOPHAGY; FRONTOTEMPORAL LOBAR DEGENERATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NF-KAPPA B; OSTEITIS DEFORMANS; SIGNAL TRANSDUCTION;

EID: 84901832434     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.01.020     Document Type: Review

References (81)

1. Akizuki M., Yamashita H., Uemura K., Maruyama H., Kawakami H., Ito H., Takahashi R. Optineurin suppression causes neuronal cell death via NF-κB pathway. J. Neurochem. 2013, 126(6):699-704.
2. Albagha O.M., Wani S.E., Visconti M.R., Alonso N., Goodman K., Brandi M.L., Cundy T., Chung P.Y., Dargie R., Devogelaer J.P., Falchetti A., Fraser W.D., Gennari L., Gianfrancesco F., Hooper M.J., Van Hul W., Isaia G., Nicholson G.C., Nuti R., Papapoulos S., Montes Jdel P., Ratajczak T., Rea S.L., Rendina D., Gonzalez-Sarmiento R., Di Stefano M., Ward L.C., Walsh J.P., Ralston S.H. Genetic Determinants of Paget[U+05F3]s Disease (GDPD) Consortium. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat. Genet. 2011, 43(7):685-689.
3. Albagha O.M., Visconti M.R., Alonso N., Wani S., Goodman K., Fraser W.D., Gennari L., Merlotti D., Gianfrancesco F., Esposito T., Rendina D., di Stefano M., Isaia G., Brandi M.L., Giusti F., Del Pino-Montes J., Corral-Gudino L., Gonzalez-Sarmiento R., Ward L., Rea S.L., Ratajczak T., Walsh J.P., Ralston S.H. Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget[U+05F3]s disease. J. Bone Miner. Res. 2013, 28(11):2338-2346.
4. Appel S.H., Rowland L.P. Amyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62: a functional convergence?. Neurology 2012, 79(15):1526-1527.
5. Arai T., Nonaka T., Hasegawa M., Akiyama H., Yoshida M., Hashizume Y., Tsuchiya K., Oda T., Ikeda K. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci. Lett. 2003, 342(1-2):41-44.
6. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351(3):602-611.
7. Asai T., Tomita Y., Nakatsuka S., Hoshida Y., Myoui A., Yoshikawa H., Aozasa K. VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn. J. Cancer Res. 2002, 93(3):296-304.
8. Azzam E.A., Helfrich M.H., Hocking L.J. Paget[U+05F3]s disease-causing mutations in Sequestosome-1 impair autophagic degradation. J. Bone Miner. Res. 2011, 26:1081. (Abstract).
9. Bastin S., Bird H., Gamble G., Cundy T. Paget[U+05F3]s disease of bone - becoming a rarity?. Rheumatology (Oxford) 2009, 48(10):1232-1235.
10. Bjørkøy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., Stenmark H., Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 2005, 171(4):603-614.
11. Buchan J.R., Kolaitis R.M., Taylor J.P., Parker R. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 2013, 153(7):1461-1474.
12. Castillo K., Nassif M., Valenzuela V., Rojas F., Matus S., Mercado G., Court F.A., van Zundert B., Hetz C. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy 2013, 9(9):1308-1320.
13. Chamoux E., Couture J., Bisson M., Morissette J., Brown J.P., Roux S. The p62 P392L mutation linked to Paget[U+05F3]s disease induces activation of human osteoclasts. Mol. Endocrinol. 2009, 23(10):1668-1680.
14. Chen S., Zhang X., Song L., Le W. Autophagy dysregulation in amyotrophic lateral sclerosis 2012, 22(1):110-116.
15. Y. Chen, Z.Z. Zheng, X. Chen, R. Huang, Y. Yang, L. Yuan, L. Pan, S. Hadano and H.F. Shang, SQSTM1 mutations in Han Chinese populations with sporadic amyotrophic lateral sclerosis, Neurobiol. Aging 35 (3) (2014) 726.e7-726.e9. http://dx.doi.org/10.1016/j.neurobiolaging.2013.09.008.
16. Criollo A., Senovilla L., Authier H., Maiuri M.C., Morselli E., Vitale I., Kepp O., Tasdemir E., Galluzzi L., Shen S., Tailler M., Delahaye N., Tesniere A., De Stefano D., Younes A.B., Harper F., Pierron G., Lavandero S., Zitvogel L., Israel A., Baud V., Kroemer G. The IKK complex contributes to the induction of autophagy. EMBO J. 2010, 29(3):619-631.
17. Crosio C., Valle C., Casciati A., Iaccarino C., Carrì M.T. Astroglial inhibition of NF-κB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS). PLoS One 2011, 6(3):e17187.
18. Custer S.K., Neumann M., Lu H., Wright A.C., Taylor J.P. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum. Mol. Genet. 2010, 19(9):1741-1755.
19. Daroszewska A., van 't Hof R.J., Rojas J.A., Layfield R., Landao-Basonga E., Rose L., Rose K., Ralston S.H. A point mutation in the ubiquitin-associated domain of SQSTM1 is sufficient to cause a Paget[U+05F3]s disease-like disorder in mice. Hum. Mol. Genet. 2011, 20(14):2734-2744.
20. DeSelm C.J., Miller B.C., Zou W., Beatty W.L., van Meel E., Takahata Y., Klumperman J., Tooze S.A., Teitelbaum S.L., Virgin H.W. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev. Cell 2011, 21(5):966-974.
21. Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., Jiang H., Hirano M., Rampersaud E., Jansen G.H., Donkervoort S., Bigio E.H., Brooks B.R., Ajroud K., Sufit R.L., Haines J.L., Mugnaini E., Pericak-Vance M.A., Siddique T. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011, 477(7363):211-215.
22. Du Y., Wooten M.C., Wooten M.W. Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease. Neurobiol. Dis. 2009, 35(2):302-310.
23. Durán A., Serrano M., Leitges M., Flores J.M., Picard S., Brown J.P., Moscat J., Diaz-Meco M.T. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell 2004, 6(2):303-309.
24. Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., Donkervoort S., Ajroud-Driss S., Sufit R.L., Heller S.L., Deng H.X., Siddique T. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011, 68(11):1440-1446.
25. Gal J., Ström A.L., Kwinter D.M., Kilty R., Zhang J., Shi P., Fu W., Wooten M.W., Zhu H. Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J. Neurochem. 2009, 111(4):1062-1073.
26. Hensley K., Fedynyshyn J., Ferrell S., Floyd R.A., Gordon B., Grammas P., Hamdheydari L., Mhatre M., Mou S., Pye Q.N., Stewart C., West M., West S., Williamson K.S. Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol. Dis. 2003, 14(1):74-80.
27. Hirano M., Nakamura Y., Saigoh K., Sakamoto H., Ueno S., Isono C., Miyamoto K., Akamatsu M., Mitsui Y., Kusunoki S. Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis Neurology 2013, 80(5):458-463.
28. Hiruma Y., Kurihara N., Subler M.A., Zhou H., Boykin C.S., Zhang H., Ishizuka S., Dempster D.W., Roodman G.D., Windle J.J.A. SQSTM1/p62 mutation linked to Paget[U+05F3]s disease increases the osteoclastogenic potential of the bone microenvironment. Hum. Mol. Genet. 2008, 17(23):3708-3719.
29. Ichimura Y., Kumanomidou T., Sou Y.S., Mizushima T., Ezaki J., Ueno T., Kominami E., Yamane T., Tanaka K., Komatsu M. Structural basis for sorting mechanism of p62 in selective autophagy. J. Biol. Chem. 2008, 283(33):22847-22857.
30. Ichimura Y., Waguri S., Sou Y.S., Kageyama S., Hasegawa J., Ishimura R., Saito T., Yang Y., Kouno T., Fukutomi T., Hoshii T., Hirao A., Takagi K., Mizushima T., Motohashi H., Lee M.S., Yoshimori T., Tanaka K., Yamamoto M., Komatsu M. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 2013, 51(5):618-631.
31. Iguchi Y., Katsuno M., Ikenaka K., Ishigaki S., Sobue G. Amyotrophic lateral sclerosis: an update on recent genetic insights. J. Neurol. 2013, 260(11):2917-2927.
32. Jiang Y.M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J., Tanaka F., Doyu M., Yoshida M., Hashizume Y., Sobue G. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann. Neurol. 2005, 57(2):236-251.
33. Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009, 187(6):875-888.
34. Jucker M., Walker L.C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013, 501(7465):45-51.
35. Kim J.E., You D.J., Lee C., Ahn C., Seong J.Y., Hwang J.I. Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation. Cell Signal. 2010, 22(11):1645-1654.
36. Komatsu M., Kageyama S., Ichimura Y. p62/SQSTM1/A170: physiology and pathology. Pharmacol. Res. 2012, 66(6):457-462.
37. Kurihara N., Hiruma Y., Zhou H., Subler M.A., Dempster D.W., Singer F.R., Reddy S.V., Gruber H.E., Windle J.J., Roodman G.D. Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J. Clin. Invest. 2007, 117(1):133-142.
38. Kuusisto E., Suuronen T., Salminen A. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. Biochem. Biophys. Res. Commun. 2001, 280(1):223-228.
39. Kwok C.T., Morris A., de Belleroche J.S. Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB. Eur. J. Hum. Genet. 2013, (in press).
40. Le Ber I., Camuzat A., Guerreiro R., Bouya-Ahmed K., Bras J., Nicolas G., Gabelle A., Didic M., De Septenville A., Millecamps S., Lenglet T., Latouche M., Kabashi E., Campion D., Hannequin D., Hardy J., Brice A. French Clinical and Genetic Research Network on FTD/FTD-ALS. SQSTM1 Mutations in French Patients With Frontotemporal Dementia or Frontotemporal Dementia With Amyotrophic Lateral Sclerosis. J. Am. Med. Assoc. Neurol. 2013, 70(11):1403-1410.
41. Lee D.Y., Brown E.J. Ubiquilins in the crosstalk among proteolytic pathways. Biol. Chem. 2012, 393(6):441-447.
42. Li L., Zhang X., Le W. Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy 2008, 4(3):290-293.
43. Li Y.R., King O.D., Shorter J., Gitler A.D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013, 201(3):361-372.
44. Linares J.F., Duran A., Yajima T., Pasparakis M., Moscat J., Diaz-Meco M.T. K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells. Mol. Cell 2013, 51(3):283-296.
45. Long J., Garner T.P., Pandya M.J., Craven C.J., Chen P., Shaw B., Williamson M.P., Layfield R., Searle M.S. Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NF-kappaB signaling. J. Mol. Biol. 2010, 396(1):178-194.
46. Mizuno Y., Amari M., Takatama M., Aizawa H., Mihara B., Okamoto K. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 2006, 249(1):13-18.
47. Moscat J., Diaz-Meco M.T., Wooten M.W. Signal integration and diversification through the p62 scaffold protein. Trends Biochem. Sci. 2007, 32(2):95-100.
48. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K., Suzuki N., Aoki M., Kawata A., Hirai T., Kato T., Ogasawara K., Hirano A., Takumi T., Kusaka H., Hagiwara K., Kaji R., Kawakami H. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465(7295):223-226.
49. Mimoto T., Miyazaki K., Morimoto N., Kurata T., Satoh K., Ikeda Y., Abe K. Impaired antioxidative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice. Brain Res. 2012, 1446:109-118.
50. Najat D., Garner T., Hagen T., Shaw B., Sheppard P.W., Falchetti A., Marini F., Brandi M.L., Long J.E., Cavey J.R., Searle M.S., Layfield R. Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget[U+05F3]s disease of bone. J. Bone Miner. Res. 2009, 24(4):632-642.
51. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314(5796):130-133.
52. Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H.A., Mackenzie I.R. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009, 132(11):2922-2931.
53. Pasquali L., Longone P., Isidoro C., Ruggieri S., Paparelli A., Fornai F. Autophagy lithium, and amyotrophic lateral sclerosis. Muscle Nerve 2009, 40(2):173-194.
54. Paul P.K., Bhatnagar S., Mishra V., Srivastava S., Darnay B.G., Choi Y., Kumar A. The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol. Cell Biol. 2012, 32(7):1248-1259.
55. Poloni M., Facchetti D., Mai R., Micheli A., Agnoletti L., Francolini G., Mora G., Camana C., Mazzini L., Bachetti T. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2000, 287(3):211-214.
56. Ralston S.H., Layfield R. Pathogenesis of Paget disease of bone. Calcif. Tissue Int. 2012, 91(2):97-113.
57. Ramesh Babu J., Lamar Seibenhener M., Peng J., Strom A.L., Kemppainen R., Cox N., Zhu H., Wooten M.C., Diaz-Meco M.T., Moscat J., Wooten M.W. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J. Neurochem. 2008, 106(1):107-120.
58. Rea S.L., Walsh J.P., Ward L., Magno A.L., Ward B.K., Shaw B., Layfield R., Kent G.N., Xu J., Ratajczak T. Sequestosome 1 mutations in Paget[U+05F3]s disease of bone in Australia: prevalence, genotype/phenotype correlation, and a novel non-UBA domain mutation (P364S) associated with increased NF-kappaB signaling without loss of ubiquitin binding. J. Bone Miner. Res. 2009, 24(7):1216-1223.
59. Rea S.L., Walsh J.P., Layfield R., Ratajczak T., Xu J. New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget[U+05F3]s disease of bone. Endocr. Rev. 2013, 34(4):501-524.
60. Rollinson S., Bennion J., Toulson G., Halliwell N., Usher S., Snowden J., Richardson A., Neary D., Mann D., Pickering-Brown S.M. Analysis of optineurin in frontotemporal lobar degeneration. Neurobiol. Aging 2012, 33(2). (425.e1-2).
61. Rubino E., Rainero I., Chiò A., Rogaeva E., Galimberti D., Fenoglio P., Grinberg Y., Isaia G., Calvo A., Gentile S., Bruni A.C., George-Hyslop P.H., Scarpini E., Gallone S., Pinessi L. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 2012, 79(15):1556-1562. TODEM Study Group.
62. Sako W., Ito H., Yoshida M., Koizumi H., Kamada M., Fujita K., Hashizume Y., Izumi Y., Kaji R. Nuclear factor κ B expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations. Clin. Neuropathol. 2012, 31(6):418-423.
63. Shimizu H., Toyoshima Y., Shiga A., Yokoseki A., Arakawa K., Sekine Y., Shimohata T., Ikeuchi T., Nishizawa M., Kakita A., Onodera O., Takahashi H. Sporadic ALS with compound heterozygous mutations in the SQSTM1 gene. Acta Neuropathol. 2013, 126(3):453-459.
64. Snowden J., Neary D., Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 2007, 114(1):31-38.
65. Song C.Y., Guo J.F., Liu Y., Tang B.S. Autophagy and its comprehensive impact on ALS. Int. J. Neurosci. 2012, 122(12):695-703.
66. Swarup V., Phaneuf D., Dupré N., Petri S., Strong M., Kriz J., Julien J.P. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways. J. Exp. Med. 2011, 208(12):2429-2447.
67. Teyssou E., Takeda T., Lebon V., Boillée S., Doukouré B., Bataillon G., Sazdovitch V., Cazeneuve C., Meininger V., LeGuern E., Salachas F., Seilhean D., Millecamps S. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol. 2013, 125(4):511-522.
68. Thomas M., Alegre-Abarrategui J., Wade-Martins R. RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum. Brain 2013, 136(Pt 5):1345-1360.
69. Ticozzi N., Tiloca C., Morelli C., Colombrita C., Poletti B., Doretti A., Maderna L., Messina S., Ratti A., Silani V. Genetics of familial Amyotrophic lateral sclerosis. Arch. Ital. Biol. 2011, 149(1):65-82.
70. Tresse E., Salomons F.A., Vesa J., Bott L.C., Kimonis V., Yao T.P., Dantuma N.P., Taylor J.P. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 2010, 6(2):217-227.
71. Turner M.R., Hardiman O., Benatar M., Brooks B.R., Chio A., de Carvalho M., Ince P.G., Lin C., Miller R.G., Mitsumoto H., Nicholson G., Ravits J., Shaw P.J., Swash M., Talbot K., Traynor B.J., Van den Berg L.H., Veldink J.H., Vucic S., Kiernan M.C. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013, 12(3):310-322.
72. UKMND-LiCALS Study Group, Morrison K.E., Dhariwal S., Hornabrook R., Savage L., Burn D.J., Khoo T.K., Kelly J., Murphy C.L., Al-Chalabi A., Dougherty A., Leigh P.N., Wijesekera L., Thornhill M., Ellis C.M., O'Hanlon K., Panicker J., Pate L., Ray P., Wyatt L., Young C.A., Copeland L., Ealing J., Hamdalla H., Leroi I., Murphy C., O'Keeffe F., Oughton E., Partington L., Paterson P., Rog D., Sathish A., Sexton D., Smith J., Vanek H., Dodds S., Williams T.L., Steen I.N., Clarke J., Eziefula C., Howard R., Orrell R., Sidle K., Sylvester R., Barrett W., Merritt C., Talbot K., Turner M.R., Whatley C., Williams C., Williams J., Cosby C., Hanemann C.O., Iman I., Philips C., Timings L., Crawford S.E., Hewamadduma C., Hibberd R., Hollinger H., McDermott C., Mils G., Rafiq M., Shaw P.J., Taylor A., Waines E., Walsh T., Addison-Jones R., Birt J., Hare M., Majid T. Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2013, 12(4):339-345.
73. Wang X., Fan H., Ying Z., Li B., Wang H., Wang G. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Neurosci. Lett. 2010, 469(1):112-116.
74. Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004, 36(4):377-381.
75. Wild P., Farhan H., McEwan D.G., Wagner S., Rogov V.V., Brady N.R., Richter B., Korac J., Waidmann O., Choudhary C., Dötsch V., Bumann D., Dikic I. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 2011, 333(6039):228-233.
76. Williams K.L., Warraich S.T., Yang S., Solski J.A., Fernando R., Rouleau G.A., Nicholson G.A., Blair I.P. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33(10). (2527.e3-10).
77. Wooten M.W., Geetha T., Seibenhener M.L., Babu J.R., Diaz-Meco M.T., Moscat J. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. J. Biol. Chem. 2005, 280(42):35625-35629.
78. Wright T., Rea S.L., Goode A., Bennett A.J., Ratajczak T., Long J.E., Searle M.S., Goldring C.E., Park B.K., Copple I.M., Layfield R. The S349T mutation of SQSTM1 links Keap1/Nrf2 signaling to Paget[U+05F3]s disease of bone. Bone 2013, 52(2):699-706.
79. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J., Takeuchi H., Doyu M., Sobue G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 2002, 80(1):158-167.
80. Zatloukal K., Stumptner C., Fuchsbichler A., Heid H., Schnoelzer M., Kenner L., Kleinert R., Prinz M., Aguzzi A., Denk H. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 2002, 160(1):255-263.
81. Zhang X., Li L., Chen S., Yang D., Wang Y., Zhang X., Wang Z., Le W. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy 2011, 7(4):412-425.